Therapeutic Area Expertise

 

JSS Medical Research India Ltd. (formerly Max Neeman International) offers a broad range of therapeutic expertise with significant experience in all major clinical indications.

 

We have successfully completed projects in all clinical phases of drug development with experience ranging from single centre studies to large multi-country trials. Our strong relationship with leading investigators and specialists provide us with access to large patient pool as well as specialized population for rare diseases.

 

Oncology is relatively more complicated than other therapeutic areas in terms of endpoints, role of comparator drugs and adverse events reporting. Patient recruitment is also often more of a challenge with oncology trials.

With the changing lifestyle, heart diseases have become a global health problem with no geographic, gender & socio-economic boundaries. Our Cardiology team is made up of experienced project managers & CRAs with access to leading cardiology investigators & patient pool. We have conducted huge number of cardiology trials that involves participation of more than 500 sites and 20,000 subjects.

The clinical development for products for infectious diseases is an increasingly viable area. Our project team members have extensive clinical experience and training in infectious disease studies involving antibiotics, antivirals and antifungal compounds as well as experience with all commonly studied populations, including populations with unique clinical issues such as HIV infection, stem cell transplantation, chronic hepatitis, multidrug resistance etc.

Our experienced ophthalmology team comprising of ophthalmic experienced clinicians, offer clinical operations and therapeutic focus on all ophthalmic programs.

Coming Soon...

Our team of clinical research professionals offers depth of experience that only a therapeutically focused CRO can offer in the area of neurological disorders like Alzheimer’s disease, cognitive disorders, stroke, multiple sclerosis, Parkinson’s disease, schizophrenia etc. 

India leads the world with largest number of diabetic patients, thereby known as “diabetes capital of the world”. According to WHO, Prevalence of diabetes mellitus 2 is estimated to be 80 million in 2030.

JSS Medical Research India Ltd. (formerly Max Neeman International) is the leading CRO supporting medical device companies in designing and execution of their clinical trials. Our outstanding operational model, quality management program including ISO 14155 certification helps guide you through the clinical development process, resulting in the clinical data critical to moving your product towards commercialization.

At JSS Medical Research India Ltd. (formerly Max Neeman International), our exclusive nutraceuticals team helps you navigate the nutraceutical regulatory guidelines and implements the latest advances in R&D techniques to drive your nutraceutical product development. 

A dedicated and experienced JSS Medical Research India Ltd. team has been set-up to conduct studies for evaluation and efficacy of biosimilars